Vincent Muczynski
Director of Biology, NovalGen Ltd / Research Fellow, University College London – Cancer Institut
"Next-generation bispecific T cell engagers with built-in autoregulation to prevent treatment-related adverse events in adoptive T cell immunotherapies."
contact : P. Martineau (IRCM)